Andere talen Prolight Diagnostics AB

Aandelen

PRLD

SE0003618230

slotkoers NORDIC GROWTH MARKET Andere beurzen 00:00:00 27-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,149 ^SEK	+2,76%		+15,50%	-50,50%

25/06	Prolight Diagnostics en TTP geven update over MicroFlex ontwikkeling	CI
17/05	Prolight Diagnostics AB (publ) rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

BioStock: Prolight's partner TTP provides update on MicroFlex development	25/06
Prolight Diagnostics and TTP Provides Update on MicroFlex Development	25/06
Warrants of series TO6 were exercised to approximately 44.8 percent and Prolight Diagnostics receives approximately SEK 9.8 million	04/06
Prolight has obtained subscription commitments for exercising warrants of series TO6 from, among others, members of the Board and management of approximately SEK 1.0 million	29/05
BioStock: Prolight Diagnostics strengthens board with experienced business developer	28/05
Last day of trading with warrants of series TO6 in Prolight Diagnostics is today, May 28, 2024	28/05
Annual general meeting of Prolight Diagnostics AB (publ) on 27 May 2024	27/05
BioStock: Prolight Diagnostics CSO comments on latest data	27/05
Prolight on track for clinical performance studies	23/05
BioStock: Prolight Diagnostics' CTO thrilled to receive UK government grant	21/05
Equity Research \| Prolight Diagnostics: SEK 17m UK grant a welcome external validation	20/05
Prolight initiates trial at London hospital Trust supported by an NIHR i4i PDA grant	20/05
The exercise period for warrants of series TO6 in Prolight Diagnostics begins today	20/05
Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development	17/05
Prolight Diagnostics publishes quarterly report Q1, 2024	17/05
Prolight Diagnostics awarded SEK17M UK government grant in collaboration with leading UK hospital Trust	17/05
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024	17/05
The exercise price for the warrants of series TO6 in Prolight Diagnostics has been determined to SEK 0.10 per share	16/05
BioStock: Prolight Diagnostics selects partner to conduct clinical validation studies	03/05
Prolight selects MDx CRO for the clinical performance studies for Psyros™	02/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Prolight Diagnostics AB

Aandelen

PRLD

SE0003618230

Andere talen

Filters